Interface reported third quarter net sales of $366.7 million, missing the $378.1 million consensus despite achieving modest year-over-year growth. While revenue was impacted by delivery shifts in the Retail and nora segments alongside economic headwinds in Europe, adjusted EPS of $0.68 exceeded expectations due to robust margin expansion and the continued execution of the "One Interface" strategy.
Key Highlights
- Adjusted gross profit margin expanded 103 basis points to 40.6%, driven by favorable pricing, product mix, and manufacturing efficiencies.
- Management lowered the full-year 2026 net sales outlook to $1.440–$1.455 billion, down from the previous range of $1.455–$1.485 billion, citing softer demand in the EMEA region.
- Healthcare billings remained a primary growth engine, increasing 5% for the quarter on top of a significant 29% growth comparison in the prior-year period.
- The company maintained a strong balance sheet with a net leverage ratio of 0.2x and total net debt reduced to $49.1 million.